remdesivir

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35215765 Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication. 2022 Jan 18 2
2 35233566 Rapidly Identifying New Coronavirus Mutations of Potential Concern in the Omicron Variant Using an Unsupervised Learning Strategy. 2022 Feb 25 1
3 35262828 In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2. 2022 Mar 9 3
4 35503561 Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice. 2022 May 18 1
5 32729392 Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19. 2021 Oct 1
6 33679150 Comparison of clinically approved molecules on SARS-CoV-2 drug target proteins: a molecular docking study. 2021 1
7 34229582 The molecular dynamics of possible inhibitors for SARS-CoV-2. 2021 Jul 6 1
8 34631362 Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex. 2021 1
9 34746476 Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs. 2021 Nov 1